BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27075428)

  • 1. Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.
    Araldi D; Ferrari LF; Levine JD
    Pain; 2016 Aug; 157(8):1773-1782. PubMed ID: 27075428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-Induced Hyperalgesic Priming in Single Nociceptors.
    Khomula EV; Araldi D; Bonet IJM; Levine JD
    J Neurosci; 2021 Jan; 41(1):31-46. PubMed ID: 33203743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperalgesic priming is restricted to isolectin B4-positive nociceptors.
    Joseph EK; Levine JD
    Neuroscience; 2010 Aug; 169(1):431-5. PubMed ID: 20457222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity.
    Ferrari LF; Araldi D; Bogen O; Green PG; Levine JD
    Neuroscience; 2019 Feb; 398():64-75. PubMed ID: 30529265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals.
    Araldi D; Khomula EV; Ferrari LF; Levine JD
    J Neurosci; 2018 Feb; 38(9):2226-2245. PubMed ID: 29431655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked sexual dimorphism in 5-HT
    Araldi D; Ferrari LF; Green P; Levine JD
    Neuroscience; 2017 Mar; 344():394-405. PubMed ID: 28040566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine-A1 receptor agonist induced hyperalgesic priming type II.
    Araldi D; Ferrari LF; Levine JD
    Pain; 2016 Mar; 157(3):698-709. PubMed ID: 26588695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.
    Araldi D; Ferrari LF; Levine JD
    J Neurosci; 2015 Sep; 35(36):12502-17. PubMed ID: 26354917
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Khomula EV; Araldi D; Levine JD
    J Neurosci; 2019 Sep; 39(36):7061-7073. PubMed ID: 31300521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.
    Araldi D; Bogen O; Green PG; Levine JD
    J Neurosci; 2019 Aug; 39(33):6414-6424. PubMed ID: 31209174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of GPCR (mu-opioid)-receptor tyrosine kinase (epidermal growth factor) crosstalk in opioid-induced hyperalgesic priming (type II).
    Araldi D; Ferrari LF; Levine JD
    Pain; 2018 May; 159(5):864-875. PubMed ID: 29447132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endothelial cells in antihyperalgesia induced by a triptan and β-blocker.
    Joseph EK; Levine JD
    Neuroscience; 2013 Mar; 232():83-9. PubMed ID: 23262231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat.
    Araldi D; Ferrari LF; Levine JD
    Neuroscience; 2018 Dec; 394():60-71. PubMed ID: 30342200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperalgesic priming (type II) induced by repeated opioid exposure: maintenance mechanisms.
    Araldi D; Ferrari LF; Levine JD
    Pain; 2017 Jul; 158(7):1204-1216. PubMed ID: 28306605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct terminal and cell body mechanisms in the nociceptor mediate hyperalgesic priming.
    Ferrari LF; Araldi D; Levine JD
    J Neurosci; 2015 Apr; 35(15):6107-16. PubMed ID: 25878283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptor subpopulations involved in hyperalgesic priming.
    Ferrari LF; Bogen O; Levine JD
    Neuroscience; 2010 Feb; 165(3):896-901. PubMed ID: 19931357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine mechanisms in oxaliplatin-induced hyperalgesic priming.
    Staurengo-Ferrari L; Araldi D; Green PG; Levine JD
    Pain; 2023 Jun; 164(6):1375-1387. PubMed ID: 36729863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat.
    Ferrari LF; Bogen O; Levine JD
    J Pain; 2014 Mar; 15(3):312-20. PubMed ID: 24407022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a novel nociceptor autocrine mechanism in chronic pain.
    Ferrari LF; Levine E; Levine JD
    Eur J Neurosci; 2013 May; 37(10):1705-13. PubMed ID: 23379641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Expression of Hyperalgesic Priming by Estrogen Receptor α in the Rat.
    Ferrari LF; Araldi D; Levine JD
    J Pain; 2017 May; 18(5):574-582. PubMed ID: 28089711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.